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Abstract Drooling as symptom of Parkinson’s disease
(PD) has thus far been poorly deﬁned. This uncertainty is
reﬂected by high variations in published prevalence rates.
The aim of this study was to investigate the prevalence of
saliva loss versus accumulation of saliva as a possible
preliminary stage, and diurnal drooling versus nocturnal
drooling. In addition, we evaluated the association between
drooling severity and the severity of facial and oral motor
disorders. We collected age, disease duration, UPDRS III
and Hoehn & Yahr stage from 104 consecutive outpatients
with PD. Diurnal and nocturnal drooling was evaluated
with a validated questionnaire (ROMP-saliva). A speech
pathologist, blinded for drooling severity, rated facial
expression, involuntary mouth opening and difﬁculty with
nose breathing and also interviewed patients about sleeping
position and nose-breathing during the night. Thirty
patients (29%) had no complaints with saliva control (‘non-
droolers’), 45 patients (43%) experienced accumulation of
saliva or only nocturnal drooling (‘pre-droolers’), and 29
(28%) had diurnal drooling (24 of which also drooled
during the night; ‘droolers’). The droolers had longer dis-
ease duration (10 vs. 7 years, p = 0.01) and drooling was
independently associated with involuntary mouth opening
(OR = 2.0; 95% CI 1.02–3.99) and swallowing complaints
(OR = 1.2; 95% CI 1.03–1.31). Diurnal drooling—deﬁned
as dribbling of saliva while awake—is present in about
28% of PD patients. This is less than usually reported.
Diurnal drooling typically appeared later in the disease
course. The association with oral motor behavior should
encourage the development of behavioral treatment
approaches.
Keywords Parkinson’s disease  Diurnal drooling 
Nocturnal drooling
Introduction
Parkinson’s disease (PD) is a common movement disorder
characterized by motor and non-motor symptoms [3, 7, 17].
Oral motor problems such as dysarthria and dysphagia are
frequently reported by PD patients. Drooling (or dribbling
of saliva) is considered a related problem. In a meta-
analysis based on 10 studies, we found that prevalence
rates of drooling varied between 32 and 74%, depending on
disease severity and deﬁnition [9]. The pooled prevalence
in community-dwelling PD patients was 56%. However,
many clinicians would feel that the prevalence rate is
lower, because overt dribbling of saliva is relatively rarely
seen in clinical practice. Complaints about saliva or
drooling can be assessed subjectively, but questionnaires
that include drooling such as SCOPA-AUT [21] and PD
NMSQuest [14] rarely make a distinction between diurnal
and nocturnal drooling. Moreover, little distinction is being
made between awareness of saliva accumulating in the
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inconsistencies in how drooling was deﬁned might explain
why published prevalence rates vary so much.
There are no data on the prevalence of accumulation of
saliva or nocturnal drooling versus diurnal drooling.
Therefore, our ﬁrst aim was to investigate the prevalence
and distribution of diurnal and nocturnal drooling in a large
cohort of community-dwelling PD patients. Second, we
aimed to test the assumption that accumulation of saliva or
mere nocturnal saliva loss is an intermediate phase leading
up towards the most severe condition of diurnal drooling,
as is expressed in the new MDS-UPDRS (Table 1)[ 6] and
the Radboud Oral Motor inventory for Parkinson’s disease
(ROMP)-saliva (Table 2)[ 8]. Third, we aimed to extend
our pilot observations that drooling is associated with facial
and oropharyngeal akinesia and male gender [10].
Methods
A total of 104 consecutive community-dwelling outpatients
with PD (according to the UK Brain Bank criteria) were
included. Data on age, disease duration, UPDRS III, Hoehn
& Yahr stage were collected. All patients completed the
Radboud Oral Motor inventory for Parkinson’s disease
(ROMP) [8]. This is a validated questionnaire consisting of
three domains: seven items with a 5-point scale for the
domains ‘speech’ and ‘swallowing’ and nine items for the
domain ‘saliva control’. We used the scores on two items
of the latter subscale to identify the presence and severity
of diurnal and nocturnal drooling (Table 2). We then
constructed three different severity groups following the
Saliva & Drooling subscale of the MDS-UPDRS (Table 1):
‘non-droolers’, i.e. patients without any complaints (score
0); ‘pre-droolers’, a term we suggest to use for patients who
only experience accumulation of saliva or only nocturnal
drooling (score 1 or 2); and ‘droolers’, meaning patients
with diurnal drooling (loss of saliva from the mouth) with
or without nocturnal drooling (score 3 or 4).
To investigate which oral and facial characteristics might
be associated with drooling severity, an experienced speech
pathologist (who was unaware of the patients’ score on the
ROMP) scaled three facial characteristics: the UPDRS
subscale for facial expression; a scale focused on mouth
opening; and a scale to score difﬁculty with nose breathing,
as previously described [10]. In addition, to explore factors
possibly related to nocturnal drooling severity, the speech
pathologists asked patients and spouses whether the patients
slept mainly on their side or mainly in the supine position,
and also whether the patient breathed mainly through the
nose or mainly through the mouth during sleeping. The
rationale behind the last variable is that when the mouth is
open, gravity directs the saliva ﬂow into the pharynx while
supine, but out of the mouth when lying sideways.
Statistical analyses
We used SPSS 16.0 for statistical analyses and p values of
\0.05 were considered signiﬁcant. The hypothesis that the
three groups differ considering disease characteristics and
oral and facial parameters was tested with one-way
ANOVA for numerical variables and the Kruskal–Wallis
Test for ordinal and nominal variables. To explore factors
that would best predict drooling, we compared the char-
acteristics between the droolers versus the non-droolers &
pre-droolers with independent t tests for continuous vari-
ables, Mann–Whitney U test for ordinal variables and chi-
square for nominal variables. We then performed a multi-
variate analysis using forward logistic regression with
drooling as the dependent variable and the signiﬁcant dis-
ease characteristics and oral-facial scores (except ROMP-
saliva) as independent variables.
Results
Of 104 patients, 30 patients (29%) were non-droolers, 45
patients (43%) pre-droolers, and 29 (28%) were droolers
Table 1 MDS-UPDRS: 2.2 saliva and drooling [6]
0: Normal: Not at all (no problems)
1: Slight: I have too much saliva, but do not drool
2: Mild: I have some drooling during sleep, but none when I am
awake
3: Moderate: I have some drooling when I am awake, but I usually
do not need tissues or an handkerchief
4: Severe: I have so much drooling that I regularly need to use
tissues or a handkerchief to protect my clothes
Table 2 Drooling severity scales (2 items from ROMP-saliva [8])
Do you experience loss of saliva during the day?
1. I do not experience loss of saliva during the day and I do not
feel increased amounts of saliva in my mouth either
2. I do not experience loss of saliva during the day but I do feel
increased amounts of saliva in my mouth
3. I experience saliva in the corners of my mouth or on my chin
4. I lose saliva on my clothes
5. I lose saliva on my clothes, but also on books or on the ﬂoor
Do you experience loss of saliva during the night?
1. I do not experience loss of saliva during the night at all
2. My pillow sometimes gets wet during the night
3. My pillow regularly gets wet during the night
4. My pillow always gets wet during the night
5. Every night my pillow and other bedclothes get wet
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Severe diurnal drooling (scores 4 or 5) was present in four
patients (4%), and in only two cases actual drooling was
visible during consultation. Nocturnal drooling (with or
without diurnal drooling) was present in 58%, in 14
patients (14%) regularly (score 3) and in ﬁve (5%) every
night and severe (score 4–5).
The distribution of disease characteristics and oral and
facialparametersforthethreesubgroupsisgiveninTable 4.
All disease characteristics and all facial, oral motor and
sleeping parameters that may be associated with drooling
show a trend of increasing difﬁculty. Differences between
the three groups were signiﬁcant except for age, difﬁculty
with nose breathing and posture and breathing during sleep.
When comparing the non-droolers & pre-droolers
(n = 75) with the droolers (n = 29), droolers were older
(68 vs. 62 years, p = 0.02), had more severe PD (UPDRS
III 31 vs. 27 points, p = 0.03), longer disease duration 10
vs. 7 years, p = 0.01), worse scores on dysphagia (ROMP-
swallowing 12 vs. 10 points; p = 0.01), worse scores on
facial expression (1.85 vs. 1.42, p = 0.01) and more severe
involuntary mouth opening (1.74 vs. 1.32; p = 0.01). Men
were equally present: 64% of non/pre-droolers and 69% of
droolers (p = 0.63). Forward logistic regression with these
variables identiﬁed involuntary mouth opening (OR = 2.0,
95% CI 1.02–3.99) and dysphagia (OR = 1.2; 95% CI
1.03–1.31) as the factors independently associated with
drooling.
Discussion
We investigated the prevalence of diurnal and nocturnal
drooling in a large cohort of community-dwelling
Table 3 Distribution of diurnal and nocturnal drooling complaints
Nocturnal drooling Total
No
(1)
Sometimes
(2)
Regularly to
always
(3–5)
Diurnal drooling
No (1) 30
a 15
b 3
b 48
Only accumulation
(2)
11
b 10
b 6
b 27
Yes (3–5) 5
c 14
c 10
c 29
Total 46 39 19 104
Interpretation for classiﬁcation in subgroups
a Group 1, No nocturnal or diurnal complaints (non-droolers)
b Group 2, Accumulation of saliva or only nocturnal drooling (pre-
droolers)
c Group 3, Diurnal drooling with or without nocturnal drooling
(droolers)
Table 4 Characteristics of subgroups
Non-droolers:
no complaints
Pre-droolers: accumulation of
saliva or only nocturnal drooling
Droolers: diurnal drooling with
or without nocturnal drooling
p value
N (%) 30 (29) 45 (43) 29 (28)
Patient characteristics
Gender (% of men) 37 82 69 0.000
Age (years; SD) 62 (10.2) 62 (10.3) 68 (9.4) 0.069
UPDRS III (SD) 24 (10.7) 28 (9.9) 31 (9.8) 0.019
Hoehn&Yahr
Mild (1–2) (%) 60 42 31 0.044
Moderate (2.5–3) (%) 37 53 62
Severe (4–5) (%) 3 5 7
Disease duration (years; SD) 6 (4.9) 7 (4.6) 10 (5.4) 0.010
ROMP-saliva control (7–35)
a 7 (0.0) 9 (3.3) 15 (4.8) 0.000
Facial and oral motor characteristics
ROMP-speech (7–35) 11 (4.2) 15 (5.1) 16 (5.7) 0.002
ROMP-swallowing (7–35) 9 (2.6) 10 (3.9) 12 (4.4) 0.006
Facial expression (0–4) 1 (0–3) 1 (1–3) 2 (0–3) 0.044
Mouth opening (1–4) 1 (1–3) 1 (1–3) 2 (1–3) 0.010
Difﬁcult nose breathing (1–4) 1 (1–2) 1 (1–3) 1 (1–3) 0.137
Sleeping characteristics
Sleeping on one side (%) 43 50 68 0.266
Breathing through the mouth (%) 36 37 57 0.291
a ROMP-saliva minus items ‘day’ and ‘night’ (see Table 2)
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123outpatients with PD. Seventy-one percent of patients con-
ﬁrmed problems with saliva or drooling, which is roughly
the prevalence that is usually cited in publications [1, 5, 16,
20]. However, here we demonstrate that actual diurnal
drooling, i.e. dribbling of saliva from the mouth while
awake, is reported by only 28% of PD patients. Among
these, severe drooling (i.e. saliva loss on clothes or on the
ﬂoor) was present in only four cases.
The prevalence rate of 28% seems more in accordance
with everyday clinical practice than the overall rate of 56%
that we estimated in a meta-analysis [9]. Furthermore, the
present observations underline the importance of being
unambiguous in drooling studies about how drooling is
deﬁned [9]. Nevertheless, drooling should not be trivialized
as the physical, emotional and social consequences can
have a major impact on everyday life [2, 11, 13].
Our results conﬁrm that saliva complaints increase with
disease severity. We also provide new evidence that the
experience of saliva accumulation or nocturnal drooling
may precede complaints about actual dribbling of saliva, as
stated by the Saliva & Drooling subscale of the MDS-
UPDRS [6]. Furthermore, our data imply that drooling is
generally not an early complaint, and that it takes an
average of 3 years to develop diurnal drooling after the
patient starts to feel accumulation of saliva or noted a wet
pillow when waking up in the morning.
Accumulation of saliva suggests hypersalivation, but
there is mounting evidence from sialometry studies that
saliva production in PD patients is normal or even lower
than in controls [4, 12, 20]. Experiencing accumulation or
loss of saliva might then be caused by a reduced swal-
lowing frequency. However, in our experience this is dif-
ﬁcult to demonstrate when patients are overtly observed
[10]. Speciﬁcally, we compared 15 droolers with 15 non-
droolers (with exclusion of pre-droolers), and demonstrated
that drooling was independently associated with hypomi-
mia (including parted lips), which was in turn associated
with dysphagia, disease severity, and male sex. In the
current study, the same facial and oral motor factors were
different between non-droolers, pre-droolers and droolers.
Moreover, when comparing non-droolers/pre-droolers with
droolers, mouth opening and dysphagia were the only
factors independently associated with drooling, consistent
with previous studies on the pathophysiology of drooling
[10, 15, 19]. But men were similarly represented in both
groups, so these results contradict our previous ﬁnding that
drooling is more common in men than in women [10].
Nocturnal drooling has rarely been studied as a speciﬁc
problem. In our cohort it was reported by 58% of patients,
but in only 18% was it present regularly or every night. It
remains important to evaluate nocturnal drooling, mainly
in relation to concurrent diurnal complaints, or as a prelude
to more severe diurnal drooling several years later. Five
patients in group 3 lost saliva exclusively during the day,
having no complaints during the night. One explanation
may be their sleeping position, as one of these patients with
most severe diurnal drooling (score 5) always slept on his
back. This reduces the risk of nocturnal saliva loss, but at
the same time may increase the risk of nocturnal aspiration
of saliva, especially in severely affected patients with
respiratory problems. Our results show a trend that sleeping
on one side and with an open mouth facilitates nocturnal
drooling. However, the reliability of these responses is
doubtful. Obviously, only objective documentation with
polysomnography would provide reliable data about posi-
tion, breathing and saliva swallowing during sleep [18].
An overall limitation of this study is the reliability of
several measures. The speech pathologist who assessed the
patients was blinded with respect to drooling status, but
was expected to do a full exam, so observation bias cannot
be ruled out. Second, our centre is a dedicated referral
centre for patients with PD, and this may have caused
referral bias. However, the basic characteristics of our
study population are comparable with other studies on
home-living PD patients with respect to age (mean
64 years), disease severity (mean UPDRS III score; median
Hoehn & Yahr stage 2.5, range 1–5) and disease duration
(8 years). This is probably because our center also attracts
large numbers of uncomplicated patients, not just patients
with advanced PD.
In conclusion, diurnal drooling deﬁned as dribbling of
saliva while awake is present in about 28% of community-
dwelling PD patients. Drooling may be preceded by the
awareness of saliva accumulation and nocturnal drooling,
and is associated with involuntary mouth opening and
swallowing complaints. These ﬁndings should encourage
the development of behavioral treatment approaches for
drooling in PD.
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